Cargando…
Evaluation of impacts of aspirin therapy versus placebo on preeclampsia: An observational study()
BACKGROUND: Gestational hypertension and pre-eclampsia often increase maternal and neonatal mortality. The illness usually appears after the 20th week of pregnancy due to malnutrition or obesity. Untreated, it can lead to neonatal and maternal mortality. Low-dose Aspirin can prevent preeclampsia if...
Autores principales: | Zhou, Liping, Wang, Zhenzhen, Wang, Li, Rastogi, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558725/ https://www.ncbi.nlm.nih.gov/pubmed/37809875 http://dx.doi.org/10.1016/j.heliyon.2023.e19527 |
Ejemplares similares
-
Preeclampsia and aspirin
por: Ahn, Tae Gyu, et al.
Publicado: (2023) -
Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017) -
Aspirin for Prevention of Preeclampsia in Lupus Pregnancy
por: Schramm, Amelie M., et al.
Publicado: (2014) -
The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta
por: Walsh, Scott W., et al.
Publicado: (2021) -
Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy
por: Stephenson, Daniel J., et al.
Publicado: (2023)